These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2567378)

  • 21. Treatment of childhood renal osteodystrophy with calcitriol or ergocalciferol.
    Hodson EM; Evans RA; Dunstan CR; Hills E; Wong SY; Rosenberg AR; Roy LP
    Clin Nephrol; 1985 Oct; 24(4):192-200. PubMed ID: 3877585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does uremic bone disease warrant early treatment with calcitriol?
    Chesney RW
    Arch Intern Med; 1980 Aug; 140(8):1016-7. PubMed ID: 6893117
    [No Abstract]   [Full Text] [Related]  

  • 23. Long-term experience of alfacalcidol in renal osteodystrophy.
    Sharman VL; Brownjohn AM; Goodwin FJ; Hately W; Manning RM; O'Riordan JH; Papapoulos SE; Marsh FP
    Q J Med; 1982; 51(203):271-8. PubMed ID: 7146311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [1 alpha-hydroxycholecalciferol in treatment of renal osteodystrophy].
    Chalmers TM; Davie MW; Hunter JO; Szaz KF
    J Urol Nephrol (Paris); 1974 Dec; 80(12):981. PubMed ID: 4617778
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment with 1-alpha hydroxy vitamin D3 of bone disease in hemodialysis. Therapeutic results and complications].
    García de Vinuesa S; Barril G; Luño J; Alles A; Jofré R; Pérez García R; Olivas E; López Gómez JM; Valderrábano F
    Rev Clin Esp; 1980 Dec; 159(5):317-22. PubMed ID: 7221095
    [No Abstract]   [Full Text] [Related]  

  • 26. Calcifediol (25-hydroxyvitamin D3) in the treatment of uremic bone disease.
    Teitelbaum SL
    Ann Intern Med; 1981 Mar; 94(3):404-5. PubMed ID: 6894359
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of 1 alpha-hydroxyvitamin D3 on experimental uremic renal osteodystrophy in rats induced by Na-sulfacetylthiazole.
    Okano K; Nakai R; Tomori T; Yoshikawa M
    Endocrinol Jpn; 1978 Dec; 25(6):553-9. PubMed ID: 751801
    [No Abstract]   [Full Text] [Related]  

  • 28. The efficacy of calcifediol in renal osteodystrophy.
    Recker R; Schoenfeld P; Letteri J; Slatopolsky E; Goldsmith R; Brickman A
    Arch Intern Med; 1978 May; 138 Spec No():857-63. PubMed ID: 646574
    [No Abstract]   [Full Text] [Related]  

  • 29. Metabolites and analogues of vitamin D. Which for what?
    Haussler MR; Cordy PE
    JAMA; 1982 Feb; 247(6):841-4. PubMed ID: 6895767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Bone histomorphometry: methodological criteria in the study of metabolic skeletal diseases].
    Coen G; Ballanti P; Taccone-Gallucci M; Bianchi AR; Bianchini G; Mazzaferro S; Milletti I; Cinotti GA
    Boll Soc Ital Biol Sper; 1981 Sep; 57(18):1873-9. PubMed ID: 6895600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Symptomatic renal osteodystrophy after renal transplantation: treatment with 1-alpha-hydroxycholecalciferol.
    Williams PS; Hillis AN; Carty AJ; Sells RA; Bone JM
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2227-8. PubMed ID: 3274500
    [No Abstract]   [Full Text] [Related]  

  • 32. Rapid suppression of plasma alkaline phosphatase activity after renal transplantation in patients with osteodystrophy.
    Cundy T; Kanis JA
    Clin Chim Acta; 1987 May; 164(3):285-91. PubMed ID: 3297429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical picture, diagnosis and therapy of renal osteodystrophy].
    Bombor H
    Z Urol Nephrol; 1977 Aug; 70(8):603-7. PubMed ID: 335702
    [No Abstract]   [Full Text] [Related]  

  • 34. [Long-term effects of a combination of 25-hydroxycholecalciferol and 1-alpha-hydroxycholecalciferol on osteodystrophy in chronic hemodialysis patients].
    Sebert JL; Marie A; Kuntz D; Marie P; Gueris J; Smadja A; Fournier A; Quichaud J
    Rev Rhum Mal Osteoartic; 1981; 48(7-9):535-41. PubMed ID: 7291931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of 1,25-dihydroxyvitamin D3 in early renal failure.
    Goodman WG; Coburn JW
    Annu Rev Med; 1992; 43():227-37. PubMed ID: 1580587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 1alpha-hydroxycholecalciferol and 25-hydroxycholecalciferol in renal bone disease.
    Fournier AE; Bordier PJ; Gueris J; Chanard J; Marie P; Ferriere C; Osario M; Bedrossian J; De Luca HF
    Calcif Tissue Res; 1976 Aug; 21 Suppl():226-35. PubMed ID: 782662
    [No Abstract]   [Full Text] [Related]  

  • 37. The Use of Vitamin D Metabolites and Analogues in the Treatment of Chronic Kidney Disease.
    Zand L; Kumar R
    Endocrinol Metab Clin North Am; 2017 Dec; 46(4):983-1007. PubMed ID: 29080646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal osteodystrophy.
    Malluche HH; Faugere MC
    N Engl J Med; 1989 Aug; 321(5):317-9. PubMed ID: 2747771
    [No Abstract]   [Full Text] [Related]  

  • 39. A model for clinical research studies of renal osteodystrophy in children.
    Norman ME; Mazur A; Gruskin AB
    Arch Intern Med; 1978 May; 138 Spec No():866-8. PubMed ID: 646576
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparative effect of 1alpha-hydroxycholecalciferol in children and adults with renal glomerular osteodystrophy.
    Henderson RG; Kanis JA; Ledingham JG; Oliver DO; Russel RG; Smith R; Walton RJ
    Calcif Tissue Res; 1976 Aug; 21 Suppl():221-5. PubMed ID: 782661
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.